Tango Therapeutics (TNGX) Current Leases (2020 - 2026)

Tango Therapeutics' Current Leases history runs 7 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• On a quarterly basis, Current Leases changed 0.28% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $2.8 million, a 0.28% change from a year earlier, with the FY2025 full-year figure at $2.7 million, up 11.57% from the prior year.
• Current Leases improved to $2.8 million in Q1 2026 per TNGX's latest filing, from $2.7 million in the prior quarter.
• Across five years, Current Leases topped out at $3.1 million in Q3 2025 and bottomed at $629000.0 in Q2 2022.
• The 5-year median for Current Leases is $2.4 million (2024), against an average of $2.2 million.
• Across the five-year window, Current Leases slipped 28.48% in 2022 and jumped 187.28% in 2023, its largest moves.
• Year by year, Current Leases stood at $1.8 million in 2022, then advanced by 17.63% to $2.1 million in 2023, then grew by 17.87% to $2.5 million in 2024, then advanced by 11.57% to $2.7 million in 2025, then advanced by 3.43% to $2.8 million in 2026.
• Per Business Quant, the three latest TNGX Current Leases figures stand at $2.8 million (Q1 2026), $2.7 million (Q4 2025), and $3.1 million (Q3 2025).